USP Chapter <797> and Preparing for a JCAHO Survey
Download in electronic PDF format for $75
Abstract: The Joint Commission on Accreditation of Healthcare Organizations (JCAHO) conducts triennial surveys of healthcare systems that wish to obtain JCAHO accreditation. Although not required, accreditation means that the facility adheres to standards that exist to ensure high-quality patient care and patient and worker safety. In April 2004, JCAHO announced that its surveys would include compliance with United States Pharmacopeia (USP) Chapter <797> standards for sterile compounding. This article is intended as a guide for hospital pharmacy administrators and compounders to prepare for the JCAHO survey. The first step is to read Chapter <797> carefully (and repeatedly, if necessary) to understand everything that needs to be done to achieve compliance. The next step is assessment of the pharmacy for compliance with those standards. A pharmacy may develop its own assessment procedure of purchase a professional prepared “gap analysis” tool to assist with the assessment. The action plan developed following this analysis should focus on implementing the following requirements as top priorities: personnel training and evaluation, beyond-use dating and labeling, verification of automated compounding devices, finished-preparation release checks and tests, and aseptic technique.
Related Keywords:
United States Pharmacopeia, USP Chapter <797>, Joint Commission on Accreditation of Healthcare Organizations, gap analysis, beyond use dating, aseptic technique, training, automated compounding devices, ACDs, documentation
Related Categories:
STERILE PREPARATIONS, UNITED STATES PHARMACOPEIA CONVENTIONS, FDA, HOSPITAL PHARMACY
Printer-Friendly Version
Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
USP Chapter <797> and Preparing for a JCAHO Survey
McElhiney Linda F
|
Jan/Feb 2005
Pg. 23-28
|
PreScription: Formal Appeals to United States Pharmacopeia Regarding USP Chapters <795>,<797>, and <825>: Part 1
Allen Loyd V Jr
|
Mar/Apr 2020
Pg. 92
|
PreScription: Formal Appeals to United States Pharmacopeia Regarding USP Chapters <795>, <797>, and <825>: Part 2
Allen Loyd V Jr
|
May/Jun 2020
Pg. 180
|
Questions and Answers: USP Chapter <797> and JCAHO Compliance
Allen Loyd V Jr
|
Jan/Feb 2005
Pg. 29-31
|
A Primer on USP Chapter 797, "Pharmaceutical Compounding - Sterile Preparations," and USP Process for Drug and Practice Standards
Newton David W, Trissel Lawrence A
|
Jul/Aug 2004
Pg. 251-263
|
United States Pharmacopeia Chapter <797> Timeline: 1989 to 2013
Newton David W
|
Jul/Aug 2013
Pg. 283-288
|
Basics of Sterile Compounding: Intravenous Admixture Preparation, Part 12: United States Pharmacopeia Chapters Referenced in the Current United States Pharmacopeia Chapter <797> Pharmaceutical Compounding -- Sterile Preparations
Allen Loyd V Jr
|
Nov/Dec 2021
Pg. 491-496
|
Misinterpretation of United States Pharmacopeia Chapter <797>
McElhiney Linda F
|
Jan/Feb 2012
Pg. 6-10
|
Microbial Air-Sampling Equipment, Part 1: Meeting United States Pharmacopeia Chapter <797> Standards
Kastango Eric S
|
May/Jun 2008
Pg. 216-229
|
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 6: 2008 Revisions to Chapter <797>
Allen Loyd V Jr, Okeke Claudia C
|
Mar/Apr 2008
Pg. 136-144
|
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 8; Stability and Beyond-Use Dating
Allen Loyd V Jr, Okeke Claudia C
|
Jul/Aug 2008
Pg. 344-353
|
Update on the Proposed Revision Process for United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations
Okeke Claudia C
|
Jul/Aug 2007
Pg. 302-305
|
Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 3: Risk Levels
Allen Loyd V Jr, Okeke Claudia C
|
Sep/Oct 2007
Pg. 404-410
|
Achievement of USP Chapter <797> Compliance by a 35-Bed Rural Hospital: A Case Study
Peters Gregory F, McKeon Marghi R, Nerbun Richard G
|
Nov/Dec 2007
Pg. 450-470
|
Proposed Revisions to USP Chapter <797> Pharmaceutical Compounding--Sterile Preparations
Newton David W
|
Mar/Apr 2005
Pg. 127-130
|
Quality Control: Minor Chapters, Major Impacts: What United States Pharmacopeia Chapters <51>, <61>, <62>, and <1207> Mean for Your Compounding Practice
Kelley Brian
|
Mar/Apr 2021
Pg. 115-124
|
USP Chapter <797>: Practical Solutions for Microbiology, Sterility, and Pyrogen Testing
Caputo Ross A, Huffman Anne, Reich Robert
|
Jan/Feb 2005
Pg. 11-13
|
Basics of Compounding: Considerations for Implementing USP Chapter <797> -- Sterile Preparations, Part 19: Storage and Beyond-Use Dating, Maintaining Sterility, Purity, and Stability of Dispensed and Distributed Compounded Sterile Preparations
Okeke Claudia C, Allen Loyd V Jr
|
May/Jun 2010
Pg. 232-238
|
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 7: Microbial Contamination Risk Levels, 12-Hour Use, and Immediate Use
Allen Loyd V Jr, Okeke Claudia C
|
May/Jun 2008
Pg. 252-257
|
Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 1
Martin Matt
|
Sep/Oct 2018
Pg. 401-404
|
Return to Top |